Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

C4orf31 Inhibitors

C4orf31, also known as Chromosome 4 Open Reading Frame 31, represents a protein with an enigmatic functional role and poorly understood inhibition mechanisms. Despite its identification as an open reading frame on chromosome 4, the specific biological functions of C4orf31 remain elusive, and consequently, the inhibition strategies targeting this protein are yet to be delineated. Computational analyses and bioinformatic predictions have hinted at potential roles for C4orf31 in cellular processes such as gene regulation, signal transduction, and protein trafficking, yet experimental validation of these hypotheses is lacking. Moreover, the absence of characterized structural domains or functional motifs within C4orf31 complicates efforts to elucidate its precise molecular functions and inhibition mechanisms.

Inhibition of C4orf31 presents a challenging endeavor due to the dearth of knowledge regarding its biochemical properties and regulatory pathways. Scenarios based on computational predictions propose that inhibition of C4orf31 may involve interference with its post-translational modifications, disruption of protein-protein interactions, or modulation of upstream signaling cascades that regulate its activity. Strategies targeting potential binding partners or critical residues within C4orf31 could potentially hinder its function, although experimental validation of these approaches is necessary to confirm their efficacy. Additionally, further investigation into the structural characteristics and functional domains of C4orf31 may unveil novel inhibition strategies by identifying vulnerabilities or druggable sites within the protein. Overall, elucidating the inhibition mechanisms of C4orf31 requires concerted efforts combining computational analyses with experimental validations to unravel its functional significance.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

Inhibits V-ATPases which can alter endosomal pH, potentially affecting the processing and signaling of neurotrophic factors like NDNF.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Another PI3K inhibitor, similar in effect to Wortmannin, possibly altering signaling pathways upstream of NDNF.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor, affects MAPK/ERK pathway which is involved in the response to neurotrophic factors.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor, which may influence cellular responses to neurotrophic factors.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, altering signaling pathways that could modulate neurotrophic factor activities.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor, can affect the PI3K/AKT/mTOR pathway, which is linked to neurotrophic signaling.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$92.00
$204.00
19
(1)

Hedgehog signaling pathway inhibitor, potentially affecting neurotrophic factor regulation.

BML-275

866405-64-3sc-200689
sc-200689A
5 mg
25 mg
$94.00
$348.00
69
(1)

Inhibits BMP signaling, which can interact with neurotrophic factor pathways.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

ROCK inhibitor, potentially affecting the actin cytoskeleton and related neurotrophic factor signaling.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$148.00
$597.00
75
(4)

Rac1 inhibitor, can affect GTPase signaling and potentially influence neurotrophic factor activity.